| ²é¿´: 1018 | »Ø¸´: 11 | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß xinniwo µÄ 2 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
[½»Á÷]
PhD student, postdoctoral position and CSC student
|
|||
|
One Junior Postdoc position for 1 year and can extend to another two years, and 1~2 CSC Phd/postdoc or visiting scholar are available in the laboratory of Prof. Philipp Kaldis at Lund University. We are using a combination of omics-approaches (RNAseq, ChIPseq, metabolomics, and lipidomics) and mouse genetics to study how metabolism is re-wired during liver disease and diabetes as a function of cell division. We are looking for a postdoctoral fellow/PhD student/visiting scholar that can drive this project and will be collaborating with multiple research groups internationally.. We are located at the Lund University, Clinical Research Centre (CRC) in Malmö, Sweden, which is an excellent environment to do research with many research and clinical groups close by. Requirements: • Master/PhD in Cell, Molecular Biology, Biochemistry, or Genetics • Experience in liver biology, mouse genetics, or metabolism will be a bonus 1.ÓÐÒâÕßÇ뽫¸öÈ˼òÀúͶµÝÖÁphilipp.kaldis@med.lu.se, cc: lina.zhao@med.lu.se 2.½ÌÊÚÃæÊÔ: Ó¢ÎĽéÉÜ×Ô¼º²©Ê¿ÆÚ¼ä¿ÆÑÐÏà¹Ø¹¤×÷¡£ |
» ²ÂÄãϲ»¶
Tosylate-DPA-714½éµ¼¹⁸F-DPA-714 PET³ÉÏñµÄÇ°ÑØ½øÕ¹
ÒѾÓÐ0È˻ظ´
I-BRD9: BRD9äå½á¹¹Óò»¯Ñ§Ì½Õ룬BETÑ¡ÔñÐÔ>700±¶
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ107È˻ظ´
ĪÄÇÀûÖéµ¥¿¹×è¶ÏNKG2A/HLA-EÒÖÖÆÍ¨Â· | Biochempartner
ÒѾÓÐ0È˻ظ´
GSPT1¿Ú·þ·Ö×Ó½º½µ½â¼ÁMRT-2359 | Biochempartner
ÒѾÓÐ0È˻ظ´
̼ÇàùϩÀ࿹ÉúËØÎªºÎÐèÁªÓÃÎ÷˾Ëû¶¡ÄÆ£¿ | Biochempartner
ÒѾÓÐ0È˻ظ´
Ô´×ÔÞ§ÀàÖ²ÎïµÄ¿¹Ñ×ÃÀ°×»îÐÔ·Ö×ÓÈ¥¼×Ñõ»ù¼Ô¹ûÞ§ËØ | Biochempartner
ÒѾÓÐ0È˻ظ´
³¦µÀÀïµÄ"´úл¿ª¹Ø"£ºFexaramineÓó¦µÀÏÞÖÆÐÔÖØÐ¶¨Òå FXR ¼¤¶¯¼Á
ÒѾÓÐ0È˻ظ´
DMXAA£º´ÓѪ¹ÜÆÆ»µ¼Áµ½STINGͨ·Ñо¿µÄ¹Ø¼ü¹¤¾ß·Ö×Ó | Biochempartner
ÒѾÓÐ0È˻ظ´
°ÐÏòPD-L1µÄÈËÔ´»¯µ¥¿Ë¡¿¹Ìå°¢ÌØÖéµ¥¿¹
ÒѾÓÐ0È˻ظ´
"̽ÕëÖ®¸¸"(+)-JQ-1ÈçºÎ¸Ä±ä±í¹ÛÒÅ´«Ñо¿ | Biochempartner
ÒѾÓÐ0È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
´úÓÑÕ÷£¨ÉϺ££©-½Õ㻦¶ÀÅ®Éú£¬µÈÒ»¸öÄêϵÄËû
+3/312
¡¾¹ú¼Ò½ÜÇàÍŶӲ©Ê¿ºóÕÐÆ¸¡¿´óÁ¬Àí¹¤´óѧ¹¦ÄÜȾÁÏÑо¿ÍŶӷ®½Àò½ÌÊÚ¿ÎÌâ×é
+1/183
Õã½´óѧ»¯Ñ§¹¤³ÌÓëÉúÎ﹤³ÌѧԺ ºÍÇì¸Ö½ÌÊÚÓëԬΰÓÀ¸±½ÌÊÚÍŶÓÁªºÏÕÐÆ¸²©Ê¿ºó
+1/82
°Ä´óÀûÑÇÃÉÄÉÊ¿´óѧÕÐÆ¸µÍ̼ұ½ð½¨Ä£·½Ïò²©Ê¿Éú£¨¿ÉÌṩȫ½±£©
+1/77
ÈýµªßòÒø ÎÊÌâÇë½Ì
+1/45
¿ÆÑÐÖúÀíÕÐÆ¸ £¨¿É¶Á²©£©+²©Ê¿ºóÕÐÆ¸
+1/35
ÎÂÖÝÒ½¿Æ´óѧ¿µ¸´Ò½Ñ§ÔºÕÐÆ¸²©ºó£¡£¡
+1/32
ÉîÖ°´ó»ô·òÂüÑо¿ÔºÎü¸½·ÖÀë¿ÎÌâ×é³ÏƸ²©Ê¿ºó
+1/28
³³²»¹ýËý£¬ÎÒÓָɲ»¹ýËý
+1/28
¿Æ¼¼ºËÐÄ£¬¼ÆËã»ú·½Ïò ÎÄÕ ¸¨Öú
+1/24
ÉϺ£½»Í¨´óѧ»·¾³Ñ§Ôº£¨»·¾³´óÊý¾ÝÓëÈ˹¤ÖÇÄÜ£»»·¾³»¯Ñ§Óë»·¾³¶¾Àíѧ£©²©Ê¿ºóÕÐÆ¸¡«
+1/19
¿Æ¼¼ºËÐÄ£¬¼ÆËã»ú·½Ïò ÎÄÕ ¸¨Öú
+1/18
¼ÆËã»ú¿Æ¼¼ºËÐÄ ÆÚ¿¯
+1/14
¼ÆËã»ú¿Æ¼¼ºËÐÄ ÆÚ¿¯
+1/14
¹ú¼ÊÆÕ¿¯/Õý¹æISSN/DOI/Ò»Öܼû¿¯
+1/6
¹ã¹¤-¶»ª·æ½ÌÊÚÍŶÓÕÐÊÕ²©Ê¿Éú£¨1ѧ²©-0-1ר²©£©
+1/4
²³º£´óѧÕÐÆ¸ÐÄÀíѧ²©Ê¿1Ãû£¬ÓбàÓа²¼Ò·Ñ£¬²»ÒªÇó·ÇÉý¼´×ß
+1/4
´Ó·Ö×ÓÄ£Äâµ½¿ÆÑ§´óÄ£ÐÍ£º¼ÓÈëÉîÛÚÀí¹¤´óѧÐÂÒ»´úAI4ScienceÍŶÓ
+1/2
Urgent£¡ÖªÃûÍâ×ÊÒÇÆ÷³§¼Ò¼±ÕÐApplication Scientist£¨ÊÛǰ£©
+1/1
»ªÖÐũҵ´óѧֲÎï¿ÆÑ§¼¼ÊõѧԺÀî¹úÌïÀÏʦ¿ÎÌâ×éÀͶ¯Æ¸ÓÃÖÆ¿ÆÑÐÖúÀíÕÐÆ¸¹«¸æ
+1/1
10Â¥2021-11-28 00:19:12
¡ï
xinniwo(½ð±Ò+1): лл²ÎÓë
xinniwo(½ð±Ò+1): лл²ÎÓë
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
11Â¥2021-11-28 15:27:05
¼òµ¥»Ø¸´
tzynew2Â¥
2021-11-22 15:21
»Ø¸´
xinniwo(½ð±Ò+1): лл²ÎÓë
ii ·¢×ÔСľ³æAndroid¿Í»§¶Ë
nono20093Â¥
2021-11-22 21:25
»Ø¸´
xinniwo(½ð±Ò+1): лл²ÎÓë
`
bjdxyxy4Â¥
2021-11-22 22:02
»Ø¸´
xinniwo(½ð±Ò+1): лл²ÎÓë
¡£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
µ¶ÅüÈý¹Ø5Â¥
2021-11-23 12:32
»Ø¸´
xinniwo(½ð±Ò+1): лл²ÎÓë
miaojiabing6Â¥
2021-11-24 08:48
»Ø¸´
xinniwo(½ð±Ò+1): лл²ÎÓë
jjijjj7Â¥
2021-11-24 09:53
»Ø¸´
xinniwo(½ð±Ò+1): лл²ÎÓë
tingting19828Â¥
2021-11-25 12:59
»Ø¸´
xinniwo(½ð±Ò+1): лл²ÎÓë
tingting19829Â¥
2021-11-25 12:59
»Ø¸´
xinniwo12Â¥
2021-11-30 17:04
»Ø¸´












»Ø¸´´ËÂ¥
